Presentation is loading. Please wait.

Presentation is loading. Please wait.

Participation in Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Hisao Ogawa et al. JAMA 2008;300:2134-2141.

Similar presentations


Presentation on theme: "Participation in Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Hisao Ogawa et al. JAMA 2008;300:2134-2141."— Presentation transcript:

1 Participation in Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Hisao Ogawa et al. JAMA 2008;300:

2 Baseline Clinical Characteristics – Part I
Hisao Ogawa et al. JAMA 2008;300:

3 Baseline Clinical Characteristics – Part II
Hisao Ogawa et al. JAMA 2008;300:

4 Atherosclerotic Events
Hisao Ogawa et al. JAMA 2008;300:

5 Total Percentage of Atherosclerotic Events According to Treatment Group
Hisao Ogawa et al. JAMA 2008;300:

6 Subgroup Analysis of Incidence of Atherosclerotic Events
Hisao Ogawa et al. JAMA 2008;300:

7 Adverse Effects Hisao Ogawa et al. JAMA 2008;300:


Download ppt "Participation in Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Hisao Ogawa et al. JAMA 2008;300:2134-2141."

Similar presentations


Ads by Google